Nisa Investment Advisors, LLC Entrada Therapeutics, Inc. Transaction History
Nisa Investment Advisors, LLC
- $24.1 Billion
- Q4 2024
A detailed history of Nisa Investment Advisors, LLC transactions in Entrada Therapeutics, Inc. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 127 shares of TRDA stock, worth $1,630. This represents 0.0% of its overall portfolio holdings.
Number of Shares
127
Previous 21
504.76%
Holding current value
$1,630
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding TRDA
# of Institutions
103Shares Held
28.2MCall Options Held
34.5KPut Options Held
16.4K-
Baker Bros. Advisors LP New York, NY4.87MShares$62.5 Million0.83% of portfolio
-
Mpm Asset Management LLC Cambridge, MA4.43MShares$56.8 Million48.7% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA4.41MShares$56.6 Million28.09% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.05MShares$39.2 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X01.71MShares$22 Million0.01% of portfolio
About Entrada Therapeutics, Inc.
- Ticker TRDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 31,368,500
- Market Cap $403M
- Description
- Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in precli...